Introduction
Acute renal failure is a problem common to many medical specialties, and its investigation has become more important since the advent of successful palliative treatment, especially haemodialysis and renal replacement. Acute renal failure may be defined as a sudden reduction in renal function with a consequent rise in blood urea and creatinine levels, usually associated with anuria or oliguria of less than 400 ml/24 h/1-73 M2. The first steps in diagnosis are to exclude prerenal and postrenal causes as well as acute or chronic disease, but these aspects are not discussed here.
Acute renal failure due to intrinsic renal disease may be vascular, glomerular, or tubulointerstitial in origin. The most common cause is so-called acute tubular necrosis The overall mortality in acute renal failure from all causes has varied in different series from 32% to 57%,10 11 the former figure being among patients treated with intensive prophylactic haemodialysis. In our selected group of patients 36 died and 12 needed regular dialysis or transplantation, representing 57% who failed to recover adequate renal function. A higher mortality might have been expected, however, since most patients with acute renal failure have ATN.
Of the 36 patients who recovered at least some renal function 32 had undergone dialysis (table II) . Failure to recover renal function varied greatly between the various histological groups, and thus treatment may be planned according to whether return of function is expected or not. In particular, all the five nephrotic patients with minimal focal or mesangial lesions recovered, four needing prolonged dialysis. Eight of the nine patients with interstitial nephritis (fig 2) BRITISH MEDICAL JOURNAL The effect of the biopsy information on specific treatment was smaller but significant. The two patients with myeloma ( fig 4) had not been diagnosed before they presented with acute renal failure; confirmation of myeloma kidney allowed intensive treatment of the primary disease with cyclophosphamide, prednisone, and allopurinol with recovery of function as noted by others.12 In only two out of 10 patients whose biopsies showed afferent arteriolar and capillary thrombi had the diagnosis been made from the initial blood smear. Treatment with heparin in the haemolytic-uraemic syndrome remains controversial, but if it is to be given then patients requiring dialysis are one group in which it should be considered. Thrombolytic treatment may also be tried, although the outlook remains poor for adults and older children. 13 The treatment of interstitial nephritis has already been mentioned. In patients with extensive crescent formation treatment with combined immunosuppressants and anticoagulants has been tried, 14 . j . : . X . f . . . . . . 
Conclusions
Renal biopsy is of value in selected patients who present with acute uraemia. It may be indicated to assess prognosis, confirm a clinical diagnosis, or form a basis for attempting treatment. One indication for biopsy is prolonged oliguria when ATN has been suspected, although acute cortical necrosis is better excluded by angiography or dynamic scintigraphy. If the clinical features suggest a lesion other than ATN an early biopsy, bearing in mind the increased morbidity in this condition, permits better appreciation of the probable outlook and treatment of some lesions.
